Higashimurayama, Japan

Fumiyasu Sato

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kowa Company Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumiyasu Sato. Retrieved from https://idiyas.com/inventor/fumiyasu-sato-zwegtif4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumiyasu Sato: Innovator in Nerve Cell Protection

Introduction

Fumiyasu Sato is a notable inventor based in Higashimurayama, Japan. He has made significant contributions to the field of medicine, particularly in the area of nerve cell protection. His innovative work has led to the development of a unique medicament aimed at inhibiting nerve cell death.

Latest Patents

Fumiyasu Sato holds 1 patent for his invention titled "Nerve Cell Death Inhibitor." This patent presents a medicament that exhibits an excellent nerve cell death inhibitory action. The invention specifically relates to a nerve cell death inhibitor comprising a combination of pitavastatin and donepezil or a salt thereof. This innovative approach has the potential to significantly impact treatments for conditions associated with nerve cell degeneration.

Career Highlights

Sato is currently associated with Kowa Company Limited, where he continues to advance his research and development efforts. His work at Kowa has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of Fumiyasu Sato's notable coworkers include Yasunobu Yoshinaka and Taro Aoki. Their collaborative efforts contribute to the innovative environment at Kowa Company Limited, fostering advancements in medical technology.

Conclusion

Fumiyasu Sato's contributions to the field of nerve cell protection through his innovative patent demonstrate his commitment to improving medical treatments. His work continues to inspire advancements in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…